EZH2 and colorectal cancer: EZH2 also mediates the silencing of the Disabled Homolog2-Interacting Protein (DAB2IP), which has been implicated in the regulation of EMT and metastatic potential in colorectal cancer [84] and is a biomarker of good prognosis in medulloblastoma [85].